These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiotonic and active transport-inhibiting action of some cardiotonic glycosides and ivorine. Erjavec F, Adamic S. Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):251-61. PubMed ID: 5841182 [No Abstract] [Full Text] [Related]
11. [Comparative hemodynamic studies on various heart glycosides]. Gotsch K, Klein WW, Leb G, Pavek P, Passath A. Z Kreislaufforsch; 1972 Jul 01; 61(7):577-87. PubMed ID: 5055577 [No Abstract] [Full Text] [Related]
12. [Recent aspects of therapy with cardiac glycosides]. Bayer O, Jost F. Dtsch Med J; 1970 May 19; 21(10):675-6 passim. PubMed ID: 5523167 [No Abstract] [Full Text] [Related]
13. [Therapeutic use of digitalis and substances with analogous action. Lecture IV]. Messini M. Clin Ter; 1971 Feb 28; 56(4):307-40. PubMed ID: 5581067 [No Abstract] [Full Text] [Related]
14. [On the question of the estrogenic effect of cardiac glycosides]. Tatra G, Nissel W. Wien Med Wochenschr; 1969 Jun 14; 119(24):460-3. PubMed ID: 5801633 [No Abstract] [Full Text] [Related]
16. [Comparison of medium-range cardiac glycosides]. Assmann I, Fiehring H, Schmidt H, Hesse P, Banse P. Dtsch Gesundheitsw; 1971 Dec 09; 26(50):2355-7. PubMed ID: 5145434 [No Abstract] [Full Text] [Related]
17. Inhibition of sodium transport in frog skin by cardiac glycosides of different molecular structure. Natochin YV, Lavrova EA. Experientia; 1972 Aug 15; 28(8):942-3. PubMed ID: 4538603 [No Abstract] [Full Text] [Related]